Suppr超能文献

pCL载体系统:快速生产无辅助病毒、高滴度的重组逆转录病毒。

The pCL vector system: rapid production of helper-free, high-titer, recombinant retroviruses.

作者信息

Naviaux R K, Costanzi E, Haas M, Verma I M

机构信息

Laboratory of Genetics, The Salk Institute, San Diego, California 92186, USA.

出版信息

J Virol. 1996 Aug;70(8):5701-5. doi: 10.1128/JVI.70.8.5701-5705.1996.

Abstract

We describe the construction and characterization of retroviral vectors and packaging plasmids that produce helper-free retrovirus with titers of 1 X 10(6) to 5 X 10(6) within 48 h. These vectors contain the immediate early region of the human cytomegalovirus enhancer-promoter fused to the Moloney murine leukemia virus long terminal repeat at the TATA box in the 5' U3 region, yielding the pCL promoter. By selecting vectors designed to express genes from one of four promoters (dihydrofolate reductase, Rous sarcoma virus, long terminal repeat, or cytomegalovirus), the pCL system permits the investigator to control the level of gene expression in target cells over a 100-fold range, while maintaining uniformly high titers of virus from transiently transfected producer cells. The pCL packaging plasmids lack a packaging signal (delta-psi) and include an added safety modification that renders them self-inactivating through the deletion of the 3' U3 enhancer. Ecotropic, amphotropic (4070A), and amphotropic-mink cell focus-forming hybrid (10A1) envelope constructions have been prepared and tested, permitting flexible selection of vector pseudotype in accordance with experimental needs. Vector supernatants are free of helper virus and are of sufficiently high titer within 2 days of transient transfection in 293 cells to permit infection of more than 50% of randomly cycling target cells in culture. We demonstrated the efficacy of these vectors by using them to transfer three potent cell cycle control genes (the p16(INK4A), p53, and Rb1 genes) into human glioblastoma cells.

摘要

我们描述了逆转录病毒载体和包装质粒的构建及特性,这些载体可产生无辅助病毒的逆转录病毒,在48小时内滴度为1×10⁶至5×10⁶。这些载体包含人巨细胞病毒增强子 - 启动子的立即早期区域,在5' U3区域的TATA框处与莫洛尼鼠白血病病毒长末端重复序列融合,产生pCL启动子。通过选择设计用于从四种启动子(二氢叶酸还原酶、劳氏肉瘤病毒、长末端重复序列或巨细胞病毒)之一表达基因的载体,pCL系统允许研究者在100倍的范围内控制靶细胞中基因表达的水平,同时维持来自瞬时转染产生细胞的病毒具有一致的高滴度。pCL包装质粒缺乏包装信号(δ-ψ),并包含一项额外的安全修饰,通过缺失3' U3增强子使其自我失活。已制备并测试了嗜亲性、双嗜性(4070A)和双嗜性 - 貂细胞聚焦形成杂交型(10A1)包膜构建体,可根据实验需求灵活选择载体假型。载体上清液不含辅助病毒,在293细胞中瞬时转染后2天内滴度足够高,可感染培养中超过50%随机循环的靶细胞。我们通过将三个有效的细胞周期控制基因(p16⁽INK4A⁾、p53和Rb1基因)转移到人胶质母细胞瘤细胞中,证明了这些载体的有效性。

相似文献

引用本文的文献

本文引用的文献

7
Mutations and altered expression of p16INK4 in human cancer.人类癌症中p16INK4的突变与表达改变
Proc Natl Acad Sci U S A. 1994 Nov 8;91(23):11045-9. doi: 10.1073/pnas.91.23.11045.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验